Literature DB >> 17061293

Implementing tandem mass spectrometry as a routine tool for characterizing the complete purine and pyrimidine metabolic profile in urine samples.

Giancarlo la Marca1, Bruno Casetta, Sabrina Malvagia, Elisabetta Pasquini, Marzia Innocenti, Maria Alice Donati, Enrico Zammarchi.   

Abstract

Purines and pyrimidines are the basic constituents of DNA and RNA and constitute the basis of at least 50 other important compounds that serve equally vital but separate roles as integral components of intracellular mononucleotide pools. They maintain the supply of these basic components to the different nucleotide pools through an extremely efficient mechanism involving the degradation and recycling of the daily waste products of normal cell turnover. We have developed an LC-MS/MS diagnostic and routine monitoring method for known defects due to both purine and pyrimidine metabolism in a single analysis. Precision tests were made by spiking several urine samples with different creatinine concentrations. For nonspiked low-creatinine urine, intraday precision was in the range of 0.1-9.8% and interday precision was between 1.6 and 14.1%. For nonspiked high-creatinine urine, intraday precision was in the range 0.5-17.2% and interday precision was between 1.5 and 29%. Limit-of-detection (LOD) was in the range 0.1-10 micromol/l and limit-of-quantification (LOQ) in the range of 0.2-15 micromol/l. The current 'dilute and shoot' approach monitors many metabolites, and utilizes a reverse phase chromatographic analysis with a detection requiring 17 min of analysis time. Tandem mass spectrometry and isotope dilution technique enable the accurate quantitation of more than 30 metabolites in one analysis. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061293     DOI: 10.1002/jms.1115

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  3 in total

1.  Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.

Authors:  Eszter Balogh; Jennifer C Chandler; Máté Varga; Mona Tahoun; Dóra K Menyhárd; Gusztáv Schay; Tomas Goncalves; Renáta Hamar; Regina Légrádi; Ákos Szekeres; Olivier Gribouval; Robert Kleta; Horia Stanescu; Detlef Bockenhauer; Andrea Kerti; Hywel Williams; Veronica Kinsler; Wei-Li Di; David Curtis; Maria Kolatsi-Joannou; Hafsa Hammid; Anna Szőcs; Kristóf Perczel; Erika Maka; Gergely Toldi; Florentina Sava; Christelle Arrondel; Magdolna Kardos; Attila Fintha; Ahmed Hossain; Felipe D'Arco; Mario Kaliakatsos; Jutta Koeglmeier; William Mifsud; Mariya Moosajee; Ana Faro; Eszter Jávorszky; Gábor Rudas; Marwa H Saied; Salah Marzouk; Kata Kelen; Judit Götze; George Reusz; Tivadar Tulassay; François Dragon; Géraldine Mollet; Susanne Motameny; Holger Thiele; Guillaume Dorval; Peter Nürnberg; András Perczel; Attila J Szabó; David A Long; Kazunori Tomita; Corinne Antignac; Aoife M Waters; Kálmán Tory
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

2.  Extended diagnosis of purine and pyrimidine disorders from urine: LC MS/MS assay development and clinical validation.

Authors:  Péter Monostori; Glynis Klinke; Jana Hauke; Sylvia Richter; Jörgen Bierau; Sven F Garbade; Georg F Hoffmann; Claus-Dieter Langhans; Dorothea Haas; Jürgen G Okun
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

3.  Current literature in mass spectrometry.

Authors: 
Journal:  J Mass Spectrom       Date:  2007-01       Impact factor: 1.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.